Drug shortages homepage

Welcome to Drug Shortages Canada, the website for mandatory reporting of drug shortages and discontinuations by market authorization holders. Anyone can search the database of shortage and discontinuation reports. More information can be found on the About & Resources Page.

Early reporting of shortages and discontinuations provides Health Canada, provincial/territorial governments, drug supply chain stakeholders, and health professionals details needed to help them monitor and manage supply. Shortages can be caused by many factors. Some last longer and are more complex than others. Because companies have to report every time they cannot fully meet demand, not all of the reports on this site are cause for concern at the patient level. Most are successfully managed before they impact patients.

The shortage database has a flag that indicates ones that are Tier 3 drug shortages, which are those that could potentially have the highest impact on Canada's drug supply and health care system. A Tier 3 designation is decided by the Tier Assignment Committee (TAC), composed of federal and provincial/territorial governments, healthcare professionals, and industry stakeholders.

Ensuring people can get the medicines they need is a top priority for Health Canada. Health Canada works closely with many partners to prevent shortages, mitigate their impacts, and help resolve them when they occur.

If you would like to know more about shortages like why they happen, how long they last, the actions being taken to reduce impacts on Canadians, and actions you can take if a drug you use is in shortage, please consult the information on Canada.ca.

Below are the newest shortage and discontinuation reports and updates to existing ones.

Drug pills

LEGEND

!!T3 denotes an actual Tier 3 shortage/discontinuation

!T3 denotes an anticipated Tier 3 shortage/discontinuation

Shortage Reports

Brand name Company Name Status Strength Update Date Updated View Report
APO-RAMIPRIL APOTEX INC Actual shortage 10MG Updated Report 2025-12-19 274170
APO-CLOPIDOGREL APOTEX INC Actual shortage 300MG Updated Report 2025-12-19 269317
APO-GATIFLOXACIN APOTEX INC Actual shortage 0.3% Updated Report 2025-12-19 265272
APO-BROMFENAC APOTEX INC Actual shortage 0.07% Updated Report 2025-12-19 262439
APO-DOXAZOSIN APOTEX INC Resolved 4MG Updated Report 2025-12-19 273333
EMERADE BAUSCH HEALTH, CANADA INC. Resolved 0.5MG Updated Report 2025-12-19 192284
EMERADE BAUSCH HEALTH, CANADA INC. Resolved 0.3MG Updated Report 2025-12-19 192281
APO-RUPATADINE APOTEX INC Resolved 10MG Updated Report 2025-12-19 260656
APO-DICLO SR APOTEX INC Resolved 100MG Updated Report 2025-12-19 273336
CAELYX BAXTER CORPORATION Anticipated shortage 2MG New Report 2025-12-19 274720
OXYTOCIN INJECTION, USP FRESENIUS KABI CANADA LTD Actual shortage 10UNIT Updated Report 2025-12-19 274709
GRAVOL IM CHURCH & DWIGHT CANADA CORP Actual shortage 50MG Updated Report 2025-12-19 259413
ACH-TELMISARTAN ACCORD HEALTHCARE INC Actual shortage 40MG Updated Report 2025-12-19 216814
AMETOP GEL 4% VALEO PHARMA INC Actual shortage 40MG Updated Report 2025-12-19 265247
TEVA-FUROSEMIDE TEVA CANADA LIMITED Actual shortage 40MG Updated Report 2025-12-19 274658
JAMP CETIRIZINE TABLETS JAMP PHARMA CORPORATION Resolved 20MG Updated Report 2025-12-19 251891
CLOXACILLIN FOR INJECTION STERIMAX INC Resolved 1G Updated Report 2025-12-19 271202
CHOLESTYRAMINE-ODAN ODAN LABORATORIES LTD Actual shortage 4G Updated Report 2025-12-19 274509
APO-DESVENLAFAXINE APOTEX INC Actual shortage 50MG Updated Report 2025-12-18 272356
APO-DESVENLAFAXINE APOTEX INC Actual shortage 50MG Updated Report 2025-12-18 271859

Discontinuation Reports

Brand name Company Name Status Strength Update Date Updated View Report
EMERADE BAUSCH HEALTH, CANADA INC. To be discontinued 0.3MG New Report 2025-12-19 274742
GRAVOL IM CHURCH & DWIGHT CANADA CORP Discontinued 50MG Updated Report 2025-12-19 274712
ELOCOM ORGANON CANADA INC. To be discontinued 0.1% Updated Report 2025-12-18 272684
VESICARE ASTELLAS PHARMA CANADA INC Discontinued 5MG Updated Report 2025-12-18 274465
VESICARE ASTELLAS PHARMA CANADA INC Discontinued 10MG Updated Report 2025-12-18 274468